Why the study?
Does prophylactic daily pravastatin demonstrate maternal-fetal safety and favorable pharmacokinetics in high-risk pregnant women?
Does prophylactic daily pravastatin demonstrate maternal-fetal safety and favorable pharmacokinetics in high-risk pregnant women?
No takes yet. Share an insight, caveat, or question.
Pravastatin has biological plausibility and a favorable safety profile for preventing preeclampsia, prompting a pilot trial to evaluate its safety and pharmacokinetics in high-risk pregnant women.
Costantine et al. (2013) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: